333 related articles for article (PubMed ID: 8835589)
1. Steroid therapy and leprosy.
Ramu G
Indian J Lepr; 1996; 68(2):182-3. PubMed ID: 8835589
[No Abstract] [Full Text] [Related]
2. Do complications occur under multi-drug therapy?
Palande DD
Indian J Lepr; 1987; 59(4):369-72. PubMed ID: 3451922
[No Abstract] [Full Text] [Related]
3. Treatment of leprosy in the United States.
Levis WR
Bull N Y Acad Med; 1984 Sep; 60(7):696-711. PubMed ID: 6386081
[No Abstract] [Full Text] [Related]
4. Hot topics in leprosy.
Handa S; Dogra S
Lepr Rev; 2003 Mar; 74(1):87-8. PubMed ID: 12669939
[No Abstract] [Full Text] [Related]
5. Steroid therapy in quiet nerve paralysis.
Pfaltzgraff RE
Indian J Lepr; 1992; 64(1):115-6. PubMed ID: 1497717
[No Abstract] [Full Text] [Related]
6. [Analysis of the results of treatment of Hansen's neuritis].
Boillot F; Millan J; Boucher P; Hirzel C
Acta Leprol; 1986; 4(2):255-65. PubMed ID: 3551464
[TBL] [Abstract][Full Text] [Related]
7. [Randomized controlled trial of medical and medico-surgical treatment of Hansen's neuritis].
Boucher P; Millan J; Parent M; Moulia-Pela JP
Acta Leprol; 1999; 11(4):171-7. PubMed ID: 10987048
[TBL] [Abstract][Full Text] [Related]
8. Relapse rates following leprosy multidrug therapy.
Suite M
West Indian Med J; 2000 Sep; 49(3):210-1. PubMed ID: 11076211
[TBL] [Abstract][Full Text] [Related]
9. [Current concepts in the treatment of Hansen's disease].
Languillon J
Acta Leprol; 1980; (81):49-57. PubMed ID: 6785983
[No Abstract] [Full Text] [Related]
10. Clinical leprosy through the last seventy-five years.
Ramu G
Indian J Lepr; 2000; 72(2):199-214. PubMed ID: 11008660
[No Abstract] [Full Text] [Related]
11. Genital involvement and type I reaction in childhood leprosy.
Gupta R; Singal A; Pandhi D
Lepr Rev; 2005 Sep; 76(3):253-7. PubMed ID: 16248212
[TBL] [Abstract][Full Text] [Related]
12. Treatment with thalidomide in steroid dependency and neuritis.
Theophilus S
Lepr India; 1980 Jul; 52(3):423-8. PubMed ID: 7206639
[TBL] [Abstract][Full Text] [Related]
13. A double blow for a patient with leprosy: a reversal reaction and an adverse drug reaction.
Thangaraju P; Venkatesan S
Lancet; 2019 Oct; 394(10207):1450. PubMed ID: 31631856
[No Abstract] [Full Text] [Related]
14. The Kellersberger memorial lecture, 1984. Chemotherapy of leprosy--a tool for leprosy control.
Levy L
Ethiop Med J; 1985 Jan; 23(1):31-42. PubMed ID: 3965285
[No Abstract] [Full Text] [Related]
15. [Treatment of patients with temporomandibular joint pathology developing in lepromatous leprosy].
Sviridov BG; Robustova TG
Stomatologiia (Mosk); 1987; 66(3):41-3. PubMed ID: 3475833
[No Abstract] [Full Text] [Related]
16. Incidence of neuritis among paucibacillary leprosy patients during treatment and surveillance.
John AS
Indian J Lepr; 2004; 76(3):215-22. PubMed ID: 15835606
[TBL] [Abstract][Full Text] [Related]
17. Acute renal failure and multidrug therapy for leprosy.
Nishioka Sde A
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):259-60. PubMed ID: 9251601
[No Abstract] [Full Text] [Related]
18. Rate of relapse and reactions in MB leprosy patients after 24 and 12 months of MDT in Maharashtra.
Deshpande J; Chougule SG; Thakar UH; Revankar CR
Indian J Lepr; 2004; 76(3):229-30. PubMed ID: 15835608
[No Abstract] [Full Text] [Related]
19. Relapse rates amongst the multidrug therapy-treated leprosy patients.
Umarane SB
Indian J Lepr; 2001; 73(4):362-4. PubMed ID: 11898471
[No Abstract] [Full Text] [Related]
20. [Chemotherapy of leprosy. I. Sulfones and sulfonamides].
Leiker DL
Ned Tijdschr Geneeskd; 1979 Jun; 123(23):969-72. PubMed ID: 460449
[No Abstract] [Full Text] [Related]
[Next] [New Search]
